PRPF19 and Spinocerebellar ataxia type 3: Interestingly, acting through Prpf19, EXOC7 counteracts the degradation of polyQ aggregation and mediates toxicity in spinocerebellar ataxia type 3 (SCA3) (Chen et al. 2021).